| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/02/2005 | EP1131338B1 Method for the production of purified invasin protein and use thereof |
| 03/02/2005 | EP1039928B1 Intranasal yellow fever vaccination |
| 03/02/2005 | EP1034207B1 BIODEGRADABLE LOW MOLECULAR WEIGHT TRIBLOCK POLY(LACTIDE-co-GLYCOLIDE) POLYETHYLENE GLYCOL COPOLYMERS HAVING REVERSE THERMAL GELATION PROPERTIES |
| 03/02/2005 | EP0919617B1 Anti-human mp52 monoclonal antibody |
| 03/02/2005 | EP0846181B1 cDNA CORRESPONDING TO THE ANTIGENOME OF NONSEGMENTED NEGATIVE STRAND RNA VIRUSES, AND PROCESS FOR THE PRODUCTION OF SUCH VIRUSES ENCODING ADDITIONAL ANTIGENICALLY ACTIVE PROTEINS |
| 03/02/2005 | EP0741868B1 Immunoassays for prostate specific antigen |
| 03/02/2005 | CN1589280A Treatment of micro-organism infection |
| 03/02/2005 | CN1589278A Recombinant allergen with reduced IgE binding but undiminished T-cell antigenicity |
| 03/02/2005 | CN1589152A Novel human beta 2 integrin alpha subunit |
| 03/02/2005 | CN1589098A Prevention and treatment of diseases associated with blood coagulation |
| 03/02/2005 | CN1587407A Si RNA capable of controlling foot-and-mouth disease virus copying and infection and its preparing method and use |
| 03/02/2005 | CN1586622A Diploid cell cerebritis B vaccine and purified cerebritis B vaccine, dosage form freeze-drying and water injection |
| 03/02/2005 | CN1586235A Cow colostrum active immunological globulin thermal denaturation preserving agent |
| 03/02/2005 | CN1191362C Streptococcus antigens |
| 03/02/2005 | CN1191357C Orally immunogenic bacterial enterotoxins expressed in transgenic plants |
| 03/02/2005 | CN1191355C Process for preparing fowl paralysis virus using cntinuous avian cell line |
| 03/02/2005 | CN1191276C Humanized antibodies and method for forming same |
| 03/02/2005 | CN1191092C Multivaleng dengue virus vaccine |
| 03/02/2005 | CN1191091C Novel preventives/remedies for immunopathy |
| 03/02/2005 | CN1191090C Use of enterobaterium protein ompA associated with antigen for generating antiviral, aniparsitic or antitumoral cytotoxic response |
| 03/02/2005 | CN1191089C Use of an OmpA enterobacteriumprotein associated with the ELAGIGILTV peptide for treating melanomal |
| 03/02/2005 | CN1191075C Composition and method for increasing weight gain and feed efficiency |
| 03/01/2005 | US6861510 Immunogenic compositions against gastrin peptides |
| 03/01/2005 | US6861506 Compositions and methods for the treatment and diagnosis of breast cancer |
| 03/01/2005 | US6861408 Therapeutic anti-melanoma compounds |
| 03/01/2005 | US6861253 Polypeptide inducing antibodies neutralizing HIV |
| 03/01/2005 | US6861247 Salmonella secreted proteins and uses thereof |
| 03/01/2005 | US6861244 Inactivated influenza virus vaccine for nasal or oral application |
| 03/01/2005 | US6861234 Method of epitope discovery |
| 03/01/2005 | US6861212 NANBV diagnostics and vaccines |
| 03/01/2005 | US6861064 Encapsulation method |
| 03/01/2005 | US6861058 Relieving pain related to muscle activity or contracture, antispasmodic |
| 03/01/2005 | US6861057 Immunogenic β-amyloid peptide |
| 03/01/2005 | US6861056 Applying composition comprising interferon gamma antibodies topically to eye to treat hyperimmune reactions such as transplant rejection, uveitis, autoimmune diseases of eye |
| 03/01/2005 | CA2114631C N-acetylglucosaminyltransferase v coding sequences |
| 02/28/2005 | CA2479474A1 Polypeptides involved in fungal biofilm formation and polynucleotides encoding same, and uses thereof |
| 02/28/2005 | CA2438753A1 Genes involved in biofilm formation by the pathogenic yeast candida albicans |
| 02/25/2005 | CA2476143A1 Method for inducing cytotoxic t lymphocyte |
| 02/24/2005 | WO2005017201A1 Method of treating herpes virus infections |
| 02/24/2005 | WO2005017133A1 Coronavirus, nucleic acid, protein, and methods for the generation of vaccine, medicaments and diagnostics |
| 02/24/2005 | WO2005017130A2 Tumour cell lines nm-f9 (dsm acc2606) and nm-d4 (dsm acc2605), uses thereof |
| 02/24/2005 | WO2005017093A2 Polypeptides of streptococcus pyogenes |
| 02/24/2005 | WO2005016979A1 Etherified carbamate functional copolymers of isobutylene type monomers, and their use in curable compositions |
| 02/24/2005 | WO2005016970A2 Fully human antibodies directed against the human insulin-like growth factor-1 receptor |
| 02/24/2005 | WO2005016967A2 Modified human igf-1r antibodies |
| 02/24/2005 | WO2005016961A1 Immunogenic compositions comprising venezuelan equine encephalitis virus replicon vectors and paramyxovirus protein antigens |
| 02/24/2005 | WO2005016955A2 Nogo receptor antagonists |
| 02/24/2005 | WO2005016952A2 Polyvalent immunogen |
| 02/24/2005 | WO2005016382A1 Antibodies to c-met |
| 02/24/2005 | WO2005016381A2 Combination therapy for the treatment and prevention of cancer using epha2, pcdgf, and haah |
| 02/24/2005 | WO2005016380A1 Methods of therapy for chronic lymphocytic leukemia |
| 02/24/2005 | WO2005016379A1 Compositions and methods for manipulating levels antigen-specific antibodies in a mammal |
| 02/24/2005 | WO2005016376A1 Transfection of blood cells with mrna for immunostimulation and gene therapy |
| 02/24/2005 | WO2005016266A2 Methods for treating cardiovascular disease using a soluble ctla4 molecule |
| 02/24/2005 | WO2005016263A2 Compositions and methods for treating hyperimmune response in the eye |
| 02/24/2005 | WO2005016247A2 Dna sequences, peptides, antibodies and vaccines for prevention and treatment of sars |
| 02/24/2005 | WO2005016246A2 Modified viral particles with immunogenic properties and reduced lipid content useful for treating and preventing infectious diseases |
| 02/24/2005 | WO2005016239A2 Molecules enhancing dermal delivery of influenza vaccines |
| 02/24/2005 | WO2005016232A2 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins |
| 02/24/2005 | WO2005016115A2 Biosensors utilizing dendrimer-immobilized ligands and their use thereof |
| 02/24/2005 | WO2004113388A3 Anti alpha - folate - receptor - tetramer antibodies |
| 02/24/2005 | WO2004104031A3 Modified antiviral peptides with increased activity and cell membrane affinity |
| 02/24/2005 | WO2004099247A3 Synthetic gene encoding human carcinoembryonic antigen and uses thereof |
| 02/24/2005 | WO2004098535A9 Modified antibodies to prostate-specific membrane antigen and uses thereof |
| 02/24/2005 | WO2004073656A3 Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders |
| 02/24/2005 | WO2004069181A3 Composition for the treatment of intraocular pressure |
| 02/24/2005 | WO2004052293A3 Recombinant vaccine against flavivirus infection |
| 02/24/2005 | WO2004042352A3 Substrates of n-end rule ubiquitylation and methods for measuring the ubiquitylation of these substrates |
| 02/24/2005 | WO2004031409A3 Method for diagnosing chronic myeloid leukemia |
| 02/24/2005 | WO2004030636A3 Human papillomavirus polypeptides and immunogenic compositions |
| 02/24/2005 | WO2004005530A3 Compositions and methods for treatment and detection of multiple cancers |
| 02/24/2005 | WO2003064616A3 Compounds and methods for inducing growth arrest and apoptosis |
| 02/24/2005 | WO2003059273A3 Antibody-avidin fusion proteins as cytotoxic drugs |
| 02/24/2005 | WO2002074237A8 Compositions and methods for the therapy and diagnosis of kidney cancer |
| 02/24/2005 | US20050044588 Methods and substances for preventing and treating autoimmune disease |
| 02/24/2005 | US20050043787 Medical device with coating that promotes endothelial cell adherence |
| 02/24/2005 | US20050043529 Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
| 02/24/2005 | US20050043528 Enterococcus faecalis polynucleotides and polypeptides |
| 02/24/2005 | US20050043519 Generating immunoglobulin specific to novel antigen receptor (NAR) for use in innunodiagnostic and immunotherapy |
| 02/24/2005 | US20050043518 Monoclonal antibody for use in detection of plant protein associated with natural rubber; diagnosing latex allergies and hypersensitivity |
| 02/24/2005 | US20050043516 TACI antibodies and uses thereof |
| 02/24/2005 | US20050043511 G-protein coupled receptor lustr2 and uses thereof |
| 02/24/2005 | US20050043481 Material consisting of at least a biodegradable polymer and cyclodextrins |
| 02/24/2005 | US20050043386 2-amino-2-(ethyl or methyl)-4-{5-substituted pyrrol-2-yl}butan-1-ols, phosphates and phosphonates; antiarthritic agents; psoriasis; immunosuppressants |
| 02/24/2005 | US20050043241 Use of inhibitors of given amino acid sequence; inhibit phosphorylation of a transcription factor; can be used to treat or prevent diabetes, ionizing radiation damage, autoimmune diseases, ischemia/reperfusion injuries, heart hypertrophies, cancer |
| 02/24/2005 | US20050043212 Drug design of a preferential enzyme inhibitor of the p38 Mitogen-activated protein kinase alpha isoform |
| 02/24/2005 | US20050042775 Botulinum antitoxin compositions and methods |
| 02/24/2005 | US20050042751 Generation and use of new types of dendritic cells |
| 02/24/2005 | US20050042731 Four helical bundle cytokine family polypeptide for use in treatment, diagnosis and prevention of infection, cardiovascular, metabolic, developmental, skin, bone, inflammatory and autoimmune disorders |
| 02/24/2005 | US20050042724 Sodium-dependent phosphate cotransporter (NAPTR) for use tool in identifying modulators for treatment and prevention of cell proliferative, nervous system and cardiovascular disorders |
| 02/24/2005 | US20050042680 Single chain antigen-binding polypeptides for polymer conjugation |
| 02/24/2005 | US20050042667 Expression vector comprising nucleotide sequences coding polypeptide for use in diagnosis, treatment and prevention of immune, hematopoietic, inflammatory and tumor diseases |
| 02/24/2005 | US20050042653 Human transport protein homologs |
| 02/24/2005 | US20050042652 Identifying monoclonal antibody for use in prevention and treatment of skin disorers; immunotherapy and peptide mimetics |
| 02/24/2005 | US20050042650 EN2 gene, diagnostic and therapeutic uses thereof |
| 02/24/2005 | US20050042636 Using semaphorin-5 gene expression as diagnostic indicator of cell proliferative disorders; tissue engineering; tissue targeted therapy |
| 02/24/2005 | US20050042624 Tumor antigen |
| 02/24/2005 | US20050042313 Method to enhance the immune system and used for the prevention and treatment of infectious diseases |
| 02/24/2005 | US20050042272 Vesiles derived from t cells, production and uses |
| 02/24/2005 | US20050042235 Borrelia burgdorferi bacterin |